↓ Skip to main content

Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?

Overview of attention for article published in Critical Care, June 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs
2 blogs
twitter
31 X users
facebook
1 Facebook page

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
Published in
Critical Care, June 2014
DOI 10.1186/cc13949
Pubmed ID
Authors

Michele Yamamoto, Aurora E Pop-Vicas

Abstract

The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly becoming a major challenge in clinical and public health settings. To date, the treatment for serious CRE infections remains difficult. The intelligent use of antimicrobials and effective infection control strategies is crucial to prevent further CRE spread. Early consultation with experts in the treatment of infections with multidrug-resistant organisms is valuable in patient management. This brief review will focus on the current, yet limited, treatment options for CRE infections.

X Demographics

X Demographics

The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 <1%
Italy 1 <1%
Australia 1 <1%
Brazil 1 <1%
India 1 <1%
Mexico 1 <1%
Nigeria 1 <1%
Spain 1 <1%
Greece 1 <1%
Other 1 <1%
Unknown 151 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 16%
Researcher 20 12%
Student > Master 20 12%
Student > Postgraduate 18 11%
Student > Ph. D. Student 14 9%
Other 41 25%
Unknown 22 14%
Readers by discipline Count As %
Medicine and Dentistry 72 45%
Immunology and Microbiology 17 11%
Agricultural and Biological Sciences 16 10%
Biochemistry, Genetics and Molecular Biology 14 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 10 6%
Unknown 27 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2021.
All research outputs
#1,243,950
of 25,728,855 outputs
Outputs from Critical Care
#1,034
of 6,613 outputs
Outputs of similar age
#11,942
of 243,300 outputs
Outputs of similar age from Critical Care
#7
of 136 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,613 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,300 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.